Ladenburg Thalmann Starts Aeolus Pharmaceuticals (AOLS) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/11/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts AOLS Hot Sheet
Price: $0.00 --0%
Rating Summary:
1 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 37
Rating Summary:
1 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 37
Join SI Premium – FREE
Ladenburg Thalmann initiates coverage on Aeolus Pharmaceuticals (OTC: AOLS) with a Buy. PT $1.25.
For more ratings news on Aeolus Pharmaceuticals click here and for the rating history of Aeolus Pharmaceuticals click here.
Shares of Aeolus Pharmaceuticals closed at $0.41 yesterday.
For more ratings news on Aeolus Pharmaceuticals click here and for the rating history of Aeolus Pharmaceuticals click here.
Shares of Aeolus Pharmaceuticals closed at $0.41 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Assumes PennantPark Floating Rate Capital (PFLT) at Buy
- Jefferies Starts Plains All American (PAA) at Buy
- Hovde Group Starts First Horizon National (FHN) at Market Perform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Ladenburg Thalmann Financial ServicesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
